Carbamazepine 200 mg/1 (Carbamazepine TABLET) 200 mg/1

Carbamazepine works by blocking voltage-gated sodium channels in the brain, which reduces neuronal excitability and stabilizes hyperexcited nerve membranes. This action helps prevent the spread of abnormal electrical signals that cause seizures and neuralgia.

The dosage of Carbamazepine 200 mg is determined by a healthcare provider based on the patient's condition, age, and response to treatment. It is typically started at a low dose and gradually increased to the effective dose.

Carbamazepine is classified as a pregnancy category D drug, meaning it should be used during pregnancy only if the benefits outweigh the risks. It can cause birth defects, so women of childbearing potential should use effective contraception. It is also excreted in breast milk, so caution is advised during breastfeeding.

To order Carbamazepine 200 mg from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then provide pricing, availability, shipping, and import paperwork details.

Carbamazepine is similar to other anticonvulsants like oxcarbazepine and phenytoin in its mechanism of action. However, it is specifically effective for partial seizures and trigeminal neuralgia, while other anticonvulsants may be preferred for different types of seizures or conditions.

Carbamazepine 200 mg should be stored below 25°C, kept in the original pack, and protected from moisture. Ensure the medication is stored out of reach of children and pets.

Carbamazepine 200 mg is administered orally, with or without food. The tablets should be swallowed whole with a glass of water. The dosage and frequency are determined by a healthcare provider based on the patient's condition.

The most serious risks associated with Carbamazepine include Stevens-Johnson syndrome/TEN (severe skin reactions), aplastic anaemia, agranulocytosis (blood disorders), hepatotoxicity (liver damage), and teratogenicity (birth defects). Patients should be monitored closely for these risks.

Carbamazepine 200 mg should not be used by patients with a history of bone marrow suppression, known hypersensitivity to carbamazepine or tricyclic antidepressants, or those carrying the HLA-B*15:02 allele. It should also be avoided in patients with hepatic porphyria or those taking MAOIs.